GSK G1SK34 Income Statements

Conto economico

Quarter End	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024
	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)
Entrate totali	7,38B	6,95B	7,18B	8,15B	8,05B	7,36B	7,88B	8,01B
Reddito operativo	3,01B	2,08B	2,14B	1,95B	572M	1,49B	1,65B	188M
Reddito ante imposte	1,63B	1,91B	1,99B	1,79B	379M	1,36B	1,5B	64M
Reddito netto	1,71B	1,49B	1,62B	1,46B	350M	1,05B	1,17B	-58M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	3,23B	2,08B	2,14B	1,95B	572M	1,49B	1,65B	188M
EBITDA	3,35B	2,72B	2,59B	2,53B	1,75B	2,04B	2,28B	1,14B

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)
Entrate totali	27,89B	30,19B	30,82B	33,75B	34,1B	34,11B	34,91B	30,33B
Reddito operativo	2,17B	4,2B	5,33B	6,24B	5,08B	6,67B	8,43B	7,35B
Reddito ante imposte	1,94B	3,53B	4,8B	6,22B	6,97B	5,44B	6,48B	6,06B
Reddito netto	912M	1,53B	3,62B	4,65B	5,75B	4,39B	14,96B	4,93B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0.17	0.285	0.674	0.863	1.068	0.814	3.469	1.143
UTILE OPERATIVO	2,45B	4,39B	5,59B	6,78B	7,86B	7,22B	8,64B	7,66B
EBITDA	4,15B	7,13B	7,52B	9,37B	8,15B	9,32B	11,05B	10,11B